Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

September 2024; Volume 44,Issue 9

Reviews

  • Open Access
    Hypoxia-induced Factor-1α and its Role in Endometrial Cancer
    BEATA SMOLARZ, HONORATA ŁUKASIEWICZ, DARIUSZ SAMULAK, RADOSŁAW KOŁACIŃSKI, SARA LANGNER, MARIANNA MAKOWSKA and HANNA ROMANOWICZ
    Anticancer Research September 2024, 44 (9) 3697-3712; DOI: https://doi.org/10.21873/anticanres.17195
  • Open Access
    Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
    TAKASHI KAMIGAKI, RISHU TAKIMOTO, SACHIKO OKADA, HIROSHI IBE, ERI OGUMA and SHIGENORI GOTO
    Anticancer Research September 2024, 44 (9) 3713-3724; DOI: https://doi.org/10.21873/anticanres.17196
  • Open Access
    Oral Fenbendazole for Cancer Therapy in Humans and Animals
    JOLIE NGUYEN, THAI Q. NGUYEN, BO HAN and BA X. HOANG
    Anticancer Research September 2024, 44 (9) 3725-3735; DOI: https://doi.org/10.21873/anticanres.17197
  • Open Access
    Open, Laparoscopy-assisted, Robotic-assisted Distal Gastrectomy for Gastric Cancer: Evidence from Randomized Clinical Trials
    TORU AOYAMA, YUKIO MAEZAWA and ITARU HASHIMOTO
    Anticancer Research September 2024, 44 (9) 3737-3745; DOI: https://doi.org/10.21873/anticanres.17198

Experimental Studies

  • Open Access
    The Expression and Prognostic Value of Multiple Glucose Transporters in Cutaneous Melanoma
    WEIJIE MA, ZHONGZE LI, JIEXI WEN and SHAOFENG YAN
    Anticancer Research September 2024, 44 (9) 3747-3756; DOI: https://doi.org/10.21873/anticanres.17199
  • Open Access
    Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer
    TAKANORI JINNO, JUNPEI YAMAGUCHI, ATSUSHI OGURA, TOSHIO KOKURYO, YUKIHIRO YOKOYAMA, MASAKI SUNAGAWA, TAISUKE BABA, YUKI MURATA and TOMOKI EBATA
    Anticancer Research September 2024, 44 (9) 3757-3769; DOI: https://doi.org/10.21873/anticanres.17200
  • Open Access
    Genetic Alteration of p18INK4C and its Expression in Peripheral Blood Mononuclear Cells Were Not Associated With Progression-free Survival of Multiple Myeloma Patients After Autologous Stem Cell Transplant
    JUNAN LI and MING J. POI
    Anticancer Research September 2024, 44 (9) 3771-3776; DOI: https://doi.org/10.21873/anticanres.17201
  • Open Access
    Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue Sarcoma
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research September 2024, 44 (9) 3777-3783; DOI: https://doi.org/10.21873/anticanres.17202
  • Open Access
    Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG M KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research September 2024, 44 (9) 3785-3791; DOI: https://doi.org/10.21873/anticanres.17203
  • Open Access
    Novel Diclofenac-NO Donor With High Affinity for Human Serum Albumin Induces Endoplasmic Reticulum Stress-mediated Cell Death in Human Pancreatic Cancer Cells
    KOJI NISHI, RYO KANDA, KAHO TAKASAKI, AYANO TAMORI, YOSHIFUMI ARIMURA, SHUHEI IMOTO, HIROTAKA MURASE, KENJI TSUKIGAWA, MASAKI OTAGIRI and KEISHI YAMASAKI
    Anticancer Research September 2024, 44 (9) 3793-3798; DOI: https://doi.org/10.21873/anticanres.17204
  • You have access
    Helicobacter pylori Infection Affects the Tumor Immune Microenvironment of Esophageal Cancer Patients
    HIROKI MATSUDA, KOTA IWAHORI, TOMOHIRA TAKEOKA, RYO KATO, SHINYA URAKAWA, TAKURO SAITO, TOMOKI MAKINO, HIDETOSHI EGUCHI, YUICHIRO DOKI and HISASHI WADA
    Anticancer Research September 2024, 44 (9) 3799-3805; DOI: https://doi.org/10.21873/anticanres.17205
  • You have access
    Expression Analysis of SSTR 1, 2 and 3 in Small-cell Lung Cancer Patients as Targets for Future Peptide Receptor Radionuclide Therapy
    NITZAN SAGIE, ELIZABETH ROMANOV, YARDEN KEZERLE, AMICHAY MEIROVITZ and KIM SHEVA
    Anticancer Research September 2024, 44 (9) 3807-3812; DOI: https://doi.org/10.21873/anticanres.17206
  • Open Access
    Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk
    CHAO-HSUAN CHEN, YU-TING CHIN, SHIH-WEI HSU, LIANG-CHUN SHIH, HUI-CHI TIEN, CHIA-WEN TSAI, YUN-CHI WANG, YEN-FANG LIU, DA-TIAN BAU and WEN-SHIN CHANG
    Anticancer Research September 2024, 44 (9) 3813-3820; DOI: https://doi.org/10.21873/anticanres.17207
  • You have access
    In Silico Study of Simultaneous Integrated Boost Carbon-Ion Radiotherapy for Locally Advanced Pancreatic Cancer
    TAKU NAKAJI, MAKOTO SHINOTO, SHIGERU YAMADA and TAKU INANIWA
    Anticancer Research September 2024, 44 (9) 3821-3828; DOI: https://doi.org/10.21873/anticanres.17208
  • You have access
    Bioinformatics Analysis of the Expression and Prognostic Value of PLAU Gene in Wilms’ Tumor
    DING LI, CHEN DING, FAN HUANG, MENGMENG CHANG, ZHIYI LU, GUOWEI LI, YINGYING LI, HONGJIE GAO and FENGYIN SUN
    Anticancer Research September 2024, 44 (9) 3829-3842; DOI: https://doi.org/10.21873/anticanres.17209
  • You have access
    Evaluation of Pan-RAF Inhibitor LY3009120 on Human Uveal Melanoma Cell Line 92-1
    YU GAO, SOPHIA WENDT, SASKIA KROHN, MOOSHEER ALAMMAR, CHRISTIAN JUNGHANSS, INGO NOLTE and HUGO MURUA ESCOBAR
    Anticancer Research September 2024, 44 (9) 3843-3848; DOI: https://doi.org/10.21873/anticanres.17210
  • You have access
    Studies of the Synthesis and the Structure-activity Relationship of 3-Methylflavones
    ARISA TSUTSUMI, SATORU KAWAII and YUKO YOSHIZAWA
    Anticancer Research September 2024, 44 (9) 3849-3855; DOI: https://doi.org/10.21873/anticanres.17211
  • You have access
    NSC-38270 Exhibits Anti-invasive and Pro-apoptotic Effects on Hepatocellular Carcinoma Huh7 Cells
    JIHYE SEO, MINSEO PARK and SAYEON CHO
    Anticancer Research September 2024, 44 (9) 3857-3866; DOI: https://doi.org/10.21873/anticanres.17212
  • You have access
    Macrophage-induced Expression of TonEBP/NFAT5 Is Associated With Gefitinib Resistance and Migration in PC-9 Cells
    HEE JU SONG, SUBODH SHARMA, TAEHEE KIM, YOUNG HWAN KIM, SOO JIN KIM, MIN WOONG KANG and SANG DO LEE
    Anticancer Research September 2024, 44 (9) 3867-3874; DOI: https://doi.org/10.21873/anticanres.17213
  • You have access
    Melanocortin Receptor Agonist Bremelanotide Induces Cell Death and Growth Inhibition in Glioblastoma Cells via Suppression of Survivin Expression
    SHUHEI SUZUKI, CHIFUMI KITANAKA and MASASHI OKADA
    Anticancer Research September 2024, 44 (9) 3875-3883; DOI: https://doi.org/10.21873/anticanres.17214

Clinical Studies

  • Open Access
    First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease
    MOTOKAZU SATO, QINGHONG HAN, CHIHIRO HOZUMI, HIDEO KUJIRAOKA, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN
    Anticancer Research September 2024, 44 (9) 3885-3889; DOI: https://doi.org/10.21873/anticanres.17215
  • Open Access
    [11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
    MOTOKAZU SATO, TOSHIHIKO SATO, CHIHIRO HOZUMI, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN
    Anticancer Research September 2024, 44 (9) 3891-3898; DOI: https://doi.org/10.21873/anticanres.17216
  • You have access
    Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma
    GENTARO FUKUSHIMA, EIICHI SATO, RYUTARO UDO, TOMOYA TAGO, KENTA KASAHARA, JUNICHI MAZAKI, KENICHI IWASAKI, MASANOBU ENOMOTO, TETSUO ISHIZAKI and YUICHI NAGAKAWA
    Anticancer Research September 2024, 44 (9) 3899-3906; DOI: https://doi.org/10.21873/anticanres.17217
  • Open Access
    Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer
    HITOSHI HIRAKAWA, TARO IKEGAMI, HIDETOSHI KINJYO, YOSHIKAZU HAYASHI, SHINYA AGENA, TERUYUKI HIGA, SHUNSUKE KONDO, MASATOMO TOYAMA, HIROYUKI MAEDA and MIKIO SUZUKI
    Anticancer Research September 2024, 44 (9) 3907-3912; DOI: https://doi.org/10.21873/anticanres.17218
  • Open Access
    Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
    NOBUHARU TAMAKI, NAMI MORI, SHINTARO TAKAKI, KEIJI TSUJI, TOSHIFUMI TADA, SHINICHIRO NAKAMURA, HIRONORI OCHI, TOSHIE MASHIBA, MASAO DOISAKI, HIROYUKI MARUSAWA, HARUHIKO KOBASHI, HIDEKI FUJII, CHIKARA OGAWA, MICHIKO NONOGI, HIROTAKA ARAI, YASUSHI UCHIDA, NAOHITO URAWA, RYOICHI NARITA, TAKEHIRO AKAHANE, MASAHIKO KONDO, YUTAKA YASUI, KAORU TSUCHIYA, NAMIKI IZUMI and MASAYUKI KUROSAKI
    Anticancer Research September 2024, 44 (9) 3913-3918; DOI: https://doi.org/10.21873/anticanres.17219
  • You have access
    Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab
    KUNIHIDE MOHRI, HIDENARI NAGAI, TAKAHISA MATSUDA, YOSHINORI IGARASHI and KOJI HIGAI
    Anticancer Research September 2024, 44 (9) 3919-3929; DOI: https://doi.org/10.21873/anticanres.17220
  • You have access
    Postoperative Nutritional Assessment of Laparoscopic Versus Open Partial Hepatectomy
    KENEI FURUKAWA, MASASHI TSUNEMATSU, KOICHIRO HARUKI, SHINJI ONDA, TOMOHIKO TANIAI, KYOHEI ABE, YOSHIHIRO SHIRAI, YUTA YAMADA and TORU IKEGAMI
    Anticancer Research September 2024, 44 (9) 3931-3936; DOI: https://doi.org/10.21873/anticanres.17221
  • You have access
    Robot-assisted Surgery for Gastrointestinal Cancer Using Indocyanine Green Conjugated Endoscopic Marking Clip Under Firefly Fluorescence Imaging
    TSUTOMU NAMIKAWA, KEIICHIRO YOKOTA, MASAYA MUNEKAGE, HIROMICHI MAEDA, HIROYUKI KITAGAWA, KEN OKAMOTO, KAZUSHIGE UCHIDA, TAKAYUKI SATO, MICHIYA KOBAYASHI, KAZUHIRO HANAZAKI and SATORU SEO
    Anticancer Research September 2024, 44 (9) 3937-3943; DOI: https://doi.org/10.21873/anticanres.17222
  • You have access
    Simultaneously Detected Liver and Lung Metastases from Colorectal Carcinoma: A Potential Treatment Strategy
    KAZUHISA TAKEDA, YUTARO KIKUCHI, YU SAWADA, TAKAFUMI KUMAMOTO, JUN WATANABE, TETSUKAN WOO, CHIKARA KUNISAKI and ITARU ENDO
    Anticancer Research September 2024, 44 (9) 3945-3954; DOI: https://doi.org/10.21873/anticanres.17223
  • You have access
    The Controlling Nutritional Status (CONUT) Score Predicts Post-operatory Risks and Prognosis in Patients With Surgically Treated Colon Cancer: A Retrospective Study
    FEDERICO COZZANI, MATTEO RICCHIUTO, EDOARDO VIRGILIO, LORENZO VIANI, MATTEO ROSSINI, GIUSEPPE PEDRAZZI and PAOLO DEL RIO
    Anticancer Research September 2024, 44 (9) 3955-3964; DOI: https://doi.org/10.21873/anticanres.17224
  • You have access
    Sequential Moderate Hypofractionated Boost in Breast Cancer Patients: A Monoinstitutional Analysis of Late Side Effects
    ISABELLA PALUMBO, ANNA GIULIA BECCHETTI, ELISABETTA PERRUCCI, LORENZO FALCINELLI, SIMONETTA SALDI, VITTORIO BINI and CYNTHIA ARISTEI
    Anticancer Research September 2024, 44 (9) 3965-3971; DOI: https://doi.org/10.21873/anticanres.17225
  • Open Access
    The Predictive Value of Different Glasgow Prognostic Scores and the LabBM Score for Patients With Recurrent Glioblastoma
    DIRK RADES, OKSANA ZEMSKOVA, JAN LEPPERT and NATHAN Y. YU
    Anticancer Research September 2024, 44 (9) 3973-3981; DOI: https://doi.org/10.21873/anticanres.17226
  • You have access
    Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing
    HYUNWOO LEE, YOON AH CHO, DEOK GEUN KIM, JAE YOUNG SON and EUN YOON CHO
    Anticancer Research September 2024, 44 (9) 3983-3994; DOI: https://doi.org/10.21873/anticanres.17227
  • You have access
    Inflammatory Burden Index Prognostic Impact in Patients With Gastric Cancer After Gastrectomy: A Propensity Score-matched Analysis
    ITARU HASHIMOTO, YUTA NAKAYAMA, MIE TANABE, JYUNYA MORITA, SHINSUKE NAGASAWA, YUKIO MAEZAWA, KYOHEI KANEMATSU, TORU AOYAMA, TAKANOBU YAMADA, NORIO YUKAWA, YASUSHI RINO, AYA SAITO, TAKASHI OGATA and TAKASHI OSHIMA
    Anticancer Research September 2024, 44 (9) 3995-4001; DOI: https://doi.org/10.21873/anticanres.17228
  • You have access
    Effect of Chemoradiotherapy on Locoregional Recurrence After Pancreatectomy for Pancreatic Cancer
    MICHINORI MATSUMOTO, KENEI FURUKAWA, TADASHI UWAGAWA, YOSHIHIRO SHIRAI, MASASHI TSUNEMATSU, SHINJI ONDA, TAKESHI GOCHO, YUTA YAMADA, KOICHIRO HARUKI and TORU IKEGAMI
    Anticancer Research September 2024, 44 (9) 4003-4010; DOI: https://doi.org/10.21873/anticanres.17229
  • You have access
    Postoperative Radiotherapy Using VMAT for RNI Including IMN in Breast Cancer: Report of Short-term Follow-up
    TOMOAKI YANO, YUKA ONO, MICHIO YOSHIMURA, TOMOHIRO ONO, MAKOTO SASAKI, TAKAHIRO FUJIMOTO and TAKASHI MIZOWAKI
    Anticancer Research September 2024, 44 (9) 4011-4018; DOI: https://doi.org/10.21873/anticanres.17230
  • You have access
    Risk Factors Associated With Perioperative Skeletal Muscle Loss in Patients With Colorectal Cancer
    HAJIME KAYANO, NANA MAMURO, YUTARO KAMEI, TAKASHI OGIMI, HIROSHI MIYAKITA, YASUHIRO KANATANI, MASAKI MORI, KENICHI OKADA, KAZUO KOYANAGI and SEIICHIRO YAMAMOTO
    Anticancer Research September 2024, 44 (9) 4019-4029; DOI: https://doi.org/10.21873/anticanres.17231
  • You have access
    Clinical Significance of Body Weight Loss During Chemotherapy for Advanced Gastric Cancer Undergoing Conversion Surgery
    TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, MASATAKA SHIMONOSONO, YUKI HIRASE, YUSUKE TSURUDA, KEN SASAKI, KENJI BABA and TAKAO OHTSUKA
    Anticancer Research September 2024, 44 (9) 4031-4037; DOI: https://doi.org/10.21873/anticanres.17232
  • You have access
    Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer
    MOTONOBU UCHIYAMA, HIROAKI SHIMA, GORO KUTOMI, DAISUKE KYUNO, ASAKA WADA, YOKO KUGA, YASUAKI TAMURA, YOSHIHIKO HIROHASHI, TOSHIHIKO TORIGOE and ICHIRO TAKEMASA
    Anticancer Research September 2024, 44 (9) 4039-4047; DOI: https://doi.org/10.21873/anticanres.17233
  • You have access
    Potential of Nutritional Markers as Predictors After Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma
    SATOKO MATSUMURA, KYOICHI KAIRA, KIYOMI KUBA, HITOSHI INOUE, MEI HAMADA, TOMOKO YAMAZAKI, MITSUHIKO NAKAHIRA and YASUHIRO EBIHARA
    Anticancer Research September 2024, 44 (9) 4049-4056; DOI: https://doi.org/10.21873/anticanres.17234
  • You have access
    Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab
    KOHEI HAGIWARA, TAKASHI MATSUKI, TAKURO OKADA, CHIHIRO FUSHIMI, TAKAHITO KONDO, HIDEAKI TAKAHASHI, ISAKU OKAMOTO, KUNIHIKO TOKASHIKI, KENJI HANYU, TAKUMA KISHIDA, TATSUYA ITO, GAI YAMASHITA, KIYOAKI TSUKAHARA, TATSUO MASUBUCHI, YUICHIRO TADA, KAHO MOMIYAMA, RYOHEI YAGUCHI, NOBUHIKO ORIDATE, GO OMURA and TAKU YAMASHITA
    Anticancer Research September 2024, 44 (9) 4057-4072; DOI: https://doi.org/10.21873/anticanres.17235
  • You have access
    Risk Factors of Poor Outcomes After Colorectal Cancer Surgery for Patients With Severe Comorbidities
    TAKUYA SHIRAISHI, ARISA YAMAGUCHI, YUTA SHIBASAKI, KATSUYA OSONE, TAKUHISA OKADA, AKIHIKO SANO, MAKOTO SAKAI, HIROOMI OGAWA, MAKOTO SOHDA, KEN SHIRABE and HIROSHI SAEKI
    Anticancer Research September 2024, 44 (9) 4073-4083; DOI: https://doi.org/10.21873/anticanres.17236
  • You have access
    Effect of Nivolumab on the Quality of Life in Recurrent/Metastatic Head and Neck Cancer
    SHOTA FUJII, ISAKU OKAMOTO, TAKURO OKADA, KUNIHIKO TOKASHIKI, YURI UEDA, HIROKI SATO, TATSUYA ITO and KIYOAKI TSUKAHARA
    Anticancer Research September 2024, 44 (9) 4085-4092; DOI: https://doi.org/10.21873/anticanres.17237
  • You have access
    Efficacy of Respiration-controlled Radiotherapy Among Patients With Locally Advanced-stage Lung Cancer: A Population-based Study
    HUNG-JEN CHEN, WEN-CHIEN CHENG, CHIA-HUNG CHEN, CHIH-YEN TU, TE-CHUN HSIA, JI-AN LIANG, CHIA-CHIN LI and CHUN-RU CHIEN
    Anticancer Research September 2024, 44 (9) 4093-4100; DOI: https://doi.org/10.21873/anticanres.17238
  • You have access
    Impact of BMI and Body Composition on First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
    TAKAFUMI YAMAMOTO, TAKANORI ITO, KAZUYUKI MIZUNO, SHINYA YOKOYAMA, KENTA YAMAMOTO, NORIHIRO IMAI, YOJI ISHIZU, TAKASHI HONDA and HIROKI KAWASHIMA
    Anticancer Research September 2024, 44 (9) 4101-4111; DOI: https://doi.org/10.21873/anticanres.17239
  • You have access
    Stereotactic Ablative Radiotherapy for Early-stage Lung Cancer in Patients With Left Ventricular Assist Device: A Case Series
    KAZUHIKO HAYASHI, HIROSHI ISHIKAWA, KEI FUJIWARA, MASATAKA NAKAI, HITOSHI ONO, YASUTOSHI FUMIMOTO, NOBUYUKI TAMAKI, SHOTARO TATEKAWA, TAKERO HIRATA, TORU KIMURA, HARUHIKO HIRATA, KEISUKE TAMARI, YOSHITO TAKEDA, SHINICHI SHIMIZU, YASUSHI SHINTANI and KAZUHIKO OGAWA
    Anticancer Research September 2024, 44 (9) 4113-4117; DOI: https://doi.org/10.21873/anticanres.17240
  • You have access
    Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer
    AYUMU HOSOKAWA, HOTAKA TAMURA, AKIKO ICHIHARA, NAOYA IMAMURA, KENGO KAI, TSUYOSHI FUKUSHIMA, ATSUSHI NANASHIMA and YOSHIHIRO KOMOHARA
    Anticancer Research September 2024, 44 (9) 4119-4125; DOI: https://doi.org/10.21873/anticanres.17241
  • You have access
    Stealthy Invader: Clinically Inapparent But Rapidly Progressive Multifocal Metastatic Melanoma Unveiled as Root Cause of Liver Failure
    ALESSIA FRACCAROLI, MICHAELA BARNIKEL, GABRIEL SCHEUBECK, OLIVER BUCHSTAB, WOLFGANG G. KUNZ, LOUISA ADOLPH, CHRISTIANA GRAF, CHRISTIAN M. LANGE, HANS-JOACHIM STEMMLER and STEPHANIE SUSANNE STECHER
    Anticancer Research September 2024, 44 (9) 4127-4132; DOI: https://doi.org/10.21873/anticanres.17242

Corrigendum

  • Open Access
    Corrigendum
    SYEDA HOORULAIN AHMED
    Anticancer Research September 2024, 44 (9) 4133; DOI: https://doi.org/10.21873/anticanres.17243
Back to top
PreviousNext

In this issue

Anticancer Research: 44 (9)
Anticancer Research
Vol. 44, Issue 9
September 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
  • First-line Chemotherapy in Combination With Oral Recombinant Methioninase and a Low-methionine Diet for a Stage IV Inoperable Pancreatic-Cancer Patient Resulted in 40% Tumor Reduction and an 86% CA19-9 Biomarker Decrease
  • Stromal CD4 (+) T Cell Subsets Mediate Antitumor Cytotoxic Immune Responses in Human Colorectal Carcinoma
  • The Expression and Prognostic Value of Multiple Glucose Transporters in Cutaneous Melanoma
  • Loss of Trefoil Factor 1 Accelerates the Immune Response to Colorectal Cancer
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Corrigendum
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire